Related Experiment Video
Updated: Jun 19, 2025

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
Published on: March 1, 2011
Systematic Review on the Role of IL-6 and IL-1β in Cardiovascular Diseases
Nurlubek Katkenov1, Zhussipbek Mukhatayev1, Samat Kozhakhmetov1
1Laboratory of Microbiome, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.
Insights
Chronic inflammation drives cardiovascular diseases (CVDs). This review shows elevated Interleukin-6 (IL-6) and Interleukin-1β (IL-1β) significantly increase adverse cardiovascular events, suggesting targeted therapies.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Inflammation Research
Background:
- Cardiovascular diseases (CVDs) are a primary global health burden, strongly linked to chronic inflammatory processes.
- Key inflammatory cytokines, Interleukin-6 (IL-6) and Interleukin-1β (IL-1β), are critically involved in the pathogenesis and progression of CVDs.
Purpose of the Study:
- To systematically review and synthesize evidence on the roles of IL-6 and IL-1β in cardiovascular diseases.
- To evaluate the impact of these cytokines on cardiovascular outcomes and explore potential therapeutic targets.
Main Methods:
- A comprehensive literature search was performed in PubMed and Embase for studies published between January 2014 and December 2024.
- Included studies investigated IL-6 and/or IL-1β in CVDs across human and animal models, focusing on clinical outcomes, mechanisms, or therapies.
- Data extraction and quality assessment were conducted by two independent reviewers, with meta-analyses performed where appropriate.
Main Results:
- The review analyzed 12 studies, revealing significant associations between elevated IL-6 and conditions like peripheral artery disease, myocardial infarction, and heart failure.
- Higher IL-1β levels were correlated with poorer outcomes in coronary artery disease and heart failure.
- Meta-analyses confirmed a significant link between increased IL-6 and IL-1β levels and a higher risk of adverse cardiovascular events.
Conclusions:
- Elevated levels of IL-6 and IL-1β are strongly associated with increased risk and severity of cardiovascular diseases.
- Targeting IL-6 and IL-1β presents a promising therapeutic avenue for mitigating inflammation and improving cardiovascular health outcomes.
Abstract:
Cardiovascular diseases (CVDs) are a leading cause of global morbidity and mortality, significantly driven by chronic inflammation. Interleukin-6 (IL-6) and interleukin-1β (IL-1β) are critical inflammatory cytokines implicated in CVD progression. This systematic review evaluates the roles of IL-6 and IL-1β in CVDs by synthesizing data from relevant studies to understand their impact on cardiovascular outcomes and identify potential therapeutic interventions. A comprehensive literature search was conducted using PubMed and Embase, covering studies from January 2014 to December 2024. Inclusion criteria encompassed studies investigating IL-6 and/or IL-1β in CVDs, including human and relevant animal models, and reporting clinical outcomes, molecular mechanisms, or therapeutic interventions. Data extraction and quality assessment were performed independently by two reviewers. Our review included 12 studies focusing on the roles of IL-6 and IL-1β in various CVDs. Elevated IL-6 levels were significantly associated with peripheral artery disease, myocardial infarction, and heart failure, while IL-1β levels were linked to worse outcomes in coronary artery disease and heart failure. Meta-analyses indicated a significant association between higher IL-6 and IL-1β levels and increased risk of adverse cardiovascular events. These findings suggest that targeting IL-6 and IL-1β could offer promising therapeutic strategies for reducing inflammation and improving cardiovascular outcomes.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Overview of the Vascular System
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...

